Computed tomography‐based radiomics prediction of <scp>CTLA4</scp> expression and prognosis in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Computed tomography‐based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma

Published:2022-11-17 Issue:6 Volume:12 Page:7627-7638
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

He Hongchao¹^ORCID,Jin Zhijia²,Dai Jun¹,Wang Haofei¹,Sun Jianqi³,Xu Danfeng¹

Affiliation:

1. Department of Urology Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai China

2. Department of Radiology Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai China

3. School of Biomedical Engineering Shanghai Jiaotong University Shanghai China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5449

Reference41 articles.

1. Epidemiology of Renal Cell Carcinoma

2. Renal cell carcinoma

3. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial

4. Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial

5. Treg and CTLA-4: Two intertwining pathways to immune tolerance

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor contour irregularity on preoperative CT predicts prognosis in renal cell carcinoma: a multi-institutional study;eClinicalMedicine;2024-09

2. Radiomics nomogram based on CT radiomics features and clinical factors for prediction of Ki-67 expression and prognosis in clear cell renal cell carcinoma: a two-center study;Cancer Imaging;2024-08-06

3. Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learning;Heliyon;2024-08

4. The potential value of dual-energy CT radiomics in evaluating CD8+, CD163+ and αSMA+ cells in the tumor microenvironment of clear cell renal cell carcinoma;Clinical and Translational Oncology;2024-07-31

5. Identification of clear cell renal cell carcinoma subtypes by integrating radiomics and transcriptomics;Heliyon;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3